141 related articles for article (PubMed ID: 9667958)
1. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.
Tran TA; Mattern RH; Afargan M; Amitay O; Ziv O; Morgan BA; Taylor JE; Hoyer D; Goodman M
J Med Chem; 1998 Jul; 41(15):2679-85. PubMed ID: 9667958
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and binding properties of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues.
Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M
J Pept Sci; 1999 Mar; 5(3):113-30. PubMed ID: 10323556
[TBL] [Abstract][Full Text] [Related]
3. Conformational analyses of cyclic hexapeptide analogs of somatostatin containing arylalkyl peptoid and naphthylalanine residues.
Mattern RH; Tran TA; Goodman M
J Pept Sci; 1999 Apr; 5(4):161-75. PubMed ID: 10323196
[TBL] [Abstract][Full Text] [Related]
4. Conformational analyses of somatostatin-related cyclic hexapeptides containing peptoid residues.
Mattern RH; Tran TA; Goodman M
J Med Chem; 1998 Jul; 41(15):2686-92. PubMed ID: 9667959
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biologic activity of conformationally constrained analogs of L-363,301.
Moore SB; Grant M; Rew Y; Bosa E; Fabbri M; Kumar U; Goodman M
J Pept Res; 2005 Dec; 66(6):404-22. PubMed ID: 16316457
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and binding potencies of cyclic hexapeptide analogs of somatostatin incorporating acidic and basic peptoid residues.
Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M
J Pept Res; 1999 Feb; 53(2):134-45. PubMed ID: 10195451
[TBL] [Abstract][Full Text] [Related]
7. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
8. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
9. Development of specific and non-specific somatostatin analogs.
Nakano T; Harano Y; Emura J; Kimura T; Sakakibara S; Shigeta Y
Horm Metab Res; 1986 Feb; 18(2):98-102. PubMed ID: 2870971
[TBL] [Abstract][Full Text] [Related]
10. Highly potent cyclic disulfide antagonists of somatostatin.
Hocart SJ; Jain R; Murphy WA; Taylor JE; Coy DH
J Med Chem; 1999 Jun; 42(11):1863-71. PubMed ID: 10354394
[TBL] [Abstract][Full Text] [Related]
11. Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies.
Osapay G; Prokai L; Kim HS; Medzihradszky KF; Coy DH; Liapakis G; Reisine T; Melacini G; Zhu Q; Wang SH; Mattern RH; Goodman M
J Med Chem; 1997 Jul; 40(14):2241-51. PubMed ID: 9216843
[TBL] [Abstract][Full Text] [Related]
12. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
13. Conformational analyses by 1H NMR and computer simulations of cyclic hexapeptides related to somatostatin containing acidic and basic peptoid residues.
Mattern RH; Tran TA; Goodman M
J Pept Res; 1999 Feb; 53(2):146-60. PubMed ID: 10195452
[TBL] [Abstract][Full Text] [Related]
14. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
15. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.
Lewis I; Bauer W; Albert R; Chandramouli N; Pless J; Weckbecker G; Bruns C
J Med Chem; 2003 Jun; 46(12):2334-44. PubMed ID: 12773038
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
17. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
[TBL] [Abstract][Full Text] [Related]
18. Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units.
Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C
J Med Chem; 2002 Apr; 45(8):1665-71. PubMed ID: 11931620
[TBL] [Abstract][Full Text] [Related]
19. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
20. Cyclic hexapeptides related to somatostatin. Synthesis and biological testing.
Pattaroni C; Lucietto P; Goodman M; Yamamoto G; Vale W; Moroder L; Gazerro L; Göhring W; Schmied B; Wünsch E
Int J Pept Protein Res; 1990 Nov; 36(5):401-17. PubMed ID: 1980489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
